Fu JL - Search Results

1

Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy.

Wang S, Fu JL, Hao HF, Jiao YN, Li PP, Han SY. Wang S, et al. Among authors: fu jl. Pharmacol Res. 2021 Aug;170:105728. doi: 10.1016/j.phrs.2021.105728. Epub 2021 Jun 11. Pharmacol Res. 2021. PMID: 34119622 Review.

2

Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.

Fu JL, Hao HF, Wang S, Jiao YN, Li PP, Han SY. Fu JL, et al. J Ethnopharmacol. 2022 Nov 15;298:115607. doi: 10.1016/j.jep.2022.115607. Epub 2022 Aug 13. J Ethnopharmacol. 2022. PMID: 35973634

3

Modified Bu-Fei decoction inhibits lung metastasis via suppressing angiopoietin-like 4.

Hao H, Guo Z, Li Z, Li J, Jiang S, Fu J, Jiao Y, Deng X, Han S, Li P. Hao H, et al. Phytomedicine. 2022 Nov;106:154409. doi: 10.1016/j.phymed.2022.154409. Epub 2022 Aug 28. Phytomedicine. 2022. PMID: 36070661

4

Dandelion extract inhibits triple-negative breast cancer cell proliferation by interfering with glycerophospholipids and unsaturated fatty acids metabolism.

Wang S, Hao HF, Jiao YN, Fu JL, Guo ZW, Guo Y, Yuan Y, Li PP, Han SY. Wang S, et al. Among authors: fu jl. Front Pharmacol. 2022 Sep 6;13:942996. doi: 10.3389/fphar.2022.942996. eCollection 2022. Front Pharmacol. 2022. PMID: 36147318 Free PMC article.

5

CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis.

Han S, Hao H, Han H, Xue D, Jiao Y, Xie Y, Xu Y, Huangfu L, Fu J, Wang S, Sun H, Li P, Zhou Q. Han S, et al. Cells. 2022 Sep 29;11(19):3067. doi: 10.3390/cells11193067. Cells. 2022. PMID: 36231027 Free PMC article.

6

Targeting Ferroptosis in Cancer by Natural Products: An Updated Review.

Guo Z, Wang S, Hao H, Deng X, Fu J, Guo Y, Yuan Y, Jiao Y, Han S. Guo Z, et al. Am J Chin Med. 2023;51(3):547-574. doi: 10.1142/S0192415X23500271. Epub 2023 May 17. Am J Chin Med. 2023. PMID: 37195647 Review.

7

HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer.

Han S, Tian Z, Tian H, Han H, Zhao J, Jiao Y, Wang C, Hao H, Wang S, Fu J, Xue D, Sun H, Li P. Han S, et al. Cell Death Discov. 2023 Jun 10;9(1):181. doi: 10.1038/s41420-023-01476-0. Cell Death Discov. 2023. PMID: 37301856 Free PMC article.

8

Pitavastatin sensitizes the EGFR-TKI associated resistance in lung cancer by inhibiting YAP/AKT/BAD-BCL-2 pathway.

Liu J, Fu J, Fu P, Liu M, Liu Z, Song B. Liu J, et al. Cancer Cell Int. 2024 Jun 28;24(1):224. doi: 10.1186/s12935-024-03416-z. Cancer Cell Int. 2024. PMID: 38943199 Free PMC article.

9

Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells.

Wang CA, Hou YC, Hong YK, Tai YJ, Shen C, Hou PC, Fu JL, Wu CL, Cheng SM, Hwang DY, Su YY, Shan YS, Tsai SJ. Wang CA, et al. Among authors: fu jl. Mol Cancer. 2025 Jan 18;24(1):25. doi: 10.1186/s12943-024-02207-4. Mol Cancer. 2025. PMID: 39825392

10

Observation of a rare beta decay of the charmed baryon with a Graph Neural Network.

BESIII Collaboration. BESIII Collaboration. Nat Commun. 2025 Jan 15;16(1):681. doi: 10.1038/s41467-024-55042-y. Nat Commun. 2025. PMID: 39814737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters